A team of scientists at the National Defense Medical Center and Centers for Disease Control in Taiwan has conducted...
An agreement has been signed between the Sinopharm of China, Ministry of Health and Family Welfare, People’s Repub...
Researchers from the University of Birmingham, U.K., have developed an accurate and sensitive novel testing me...
FedEx Express, a subsidiary of FedEx Corp. and one of the world’s largest express transportation companies, delive...
ProXmask™ is the first antiviral face mask mass-produced in the Asia Pacific by Prolexus Group. The...
Thermo Fisher Scientific has announced that the U.S. Food and Drug Administration (FDA) has granted emergency use author...
US-based HDT Bio Corp has announced an agreement with Korean biotech Quratis Inc. to co-develop HDT’s revolutionar...
In response to the COVID-19 pandemic and the rise of digital consumption patterns, as well as assist companies in their ...
US-based Senhwa Biosciences, Inc. has announced that its novel oral drug, Silmitasertib, has been included in Taiwa...
The Australian government is providing COVID-19 rapid antigen testing (RAT) to residential aged care facilities in Great...
A team of researchers at the National Institute of Infectious Diseases and Vaccinology in Taiwan is providing new i...
The U.S. Food and Drug Administration (FDA) has amended the emergency use authorizations (EUAs) for both the Pfizer-BioN...
The laboratory research at Australia's Brisbane’s Translational Research Institute found pre-diabetes worsens the ...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, on Aug 10, 2021 announ...
A cross-sectional study was recently conducted to clarify the adverse events of COVID-19 vaccines in Japanese young popu...
Hong Kong-based PHASE Scientific International has announced that its INDICAID™ COVID-19 Rapid Antigen Test (...
Currently, the only treatment for COVID-19 approved by the US FDA is Remdesivir, but it has to be administered via intra...
The International Vaccine Institute (IVI) is partnering with SK bioscience of South Korea to conduct Phase III clinical ...
